Back to results
US 2012/0003150 A1Published application
Therapeutic ribonucleases
AssigneeQuintessence Biosciences, Inc.
InventorsTony Klink, John Kink, Laura Strong
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of ribonucleases (RNases) in the treatment or prevention of disease.
Claims20
A method for treating a subject comprising:
- administering a composition to a human subject, wherein said composition comprises a ribonuclease having a human RNase 1 sequence comprising SEQ ID NO:1, and wherein said human subject has cancer, is at risk for cancer, or is suspected of having cancer.
Dependencies are inferred from the claim text.